Table of Contents

company-logo

TScan Therapeutics, Inc., a preclinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell therapies for the treatment of patients with cancer. It is developing TSC-100 and TSC-101 for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation; and TSC-200, TSC-201, TSC-202, TSC-203, and TSC-204 for the treatment of solid tumors. The company is also developing vaccines for infectious diseases, such as SARS-CoV-2. It has a collaboration and license agreement with Novartis Institutes for BioMedical Research, Inc., to identify novel cancer antigens from the T cells of patients with a certain specific type of cancer. TScan Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

TScan Therapeutics Dividend Announcement

• TScan Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on TScan Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

TScan Therapeutics Dividend History

TScan Therapeutics Dividend Yield

TScan Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing TScan Therapeutics stock? Use our calculator to estimate your expected dividend yield:

TScan Therapeutics Financial Ratios

P/E ratio-4.82
PEG ratio0.26
P/B ratio2.34
ROE-58.72%
Payout ratio0.00%
Current ratio9.56
Quick ratio9.56
Cash Ratio4.64

TScan Therapeutics Dividend FAQ

Does TScan Therapeutics stock pay dividends?
TScan Therapeutics does not currently pay dividends to its shareholders.
Has TScan Therapeutics ever paid a dividend?
No, TScan Therapeutics has no a history of paying dividends to its shareholders. TScan Therapeutics is not known for its dividend payments.
Why doesn't TScan Therapeutics pay dividends?
There are several potential reasons why TScan Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will TScan Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While TScan Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is TScan Therapeutics a dividend aristocrat?
TScan Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is TScan Therapeutics a dividend king?
TScan Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is TScan Therapeutics a dividend stock?
No, TScan Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy TScan Therapeutics stocks?
To buy TScan Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy TScan Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.